{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:58:55Z","timestamp":1791356335655,"version":"4.3.1"},"reference-count":18,"publisher":"Health Affairs Publishing, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Affairs"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1377\/hlthaff.2011.0328","type":"journal-article","created":{"date-parts":[[2011,6,9]],"date-time":"2011-06-09T11:33:18Z","timestamp":1307619198000},"page":"1049-1057","source":"Crossref","is-referenced-by-count":82,"title":["Eliminating Epidemic Group A Meningococcal Meningitis In Africa Through A New Vaccine"],"prefix":"10.1377","volume":"30","author":[{"given":"F. Marc","family":"LaForce","sequence":"first","affiliation":[{"name":"F. Marc LaForce ( ) is director of the Meningitis Vaccine Project at the Program for Appropriate Technology in Health (PATH), in Washington, D.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Okwo-Bele","sequence":"additional","affiliation":[{"name":"Jean-Marie Okwo-Bele is director of the Department of Immunization, Vaccines, and Biologicals at the World Health Organization, in Geneva, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"102","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.062"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2006.00051.x"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.036"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61016-2"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1086\/644623"},{"key":"B7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/B978-1-4160-3611-1.50023-4","volume-title":"Vaccines","author":"Granoff DM","year":"2008","edition":"5"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)03366-8"},{"key":"B10","volume-title":"Introduction of a Group A meningococcal conjugate vaccine in sub-Saharan Africa: cost\/savings analysis","year":"2008"},{"issue":"40","key":"B12","first-page":"331","volume":"77","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.16.2043"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66788-8"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16725-1"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.20.2491"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003812"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.050"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2011.0295"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70307-8"},{"key":"B26","first-page":"499","volume":"77","author":"Campagne G","year":"1999","journal-title":"Bull World Health Organ"}],"container-title":["Health Affairs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.2011.0328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T15:04:10Z","timestamp":1664291050000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.2011.0328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["10.1377\/hlthaff.2011.0328"],"URL":"https:\/\/doi.org\/10.1377\/hlthaff.2011.0328","relation":{},"ISSN":["0278-2715","1544-5208"],"issn-type":[{"value":"0278-2715","type":"print"},{"value":"1544-5208","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}